News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

News

KKR makes seven times return on exit of Swiss pharma company

The firm first acquired a stake in Galenica when it bought Alliance Boots in 2007

KKR makes seven times return on exit of Swiss pharma company

US-based buyout giant KKR has sold its stake in Switzerland-listed pharmaceutical company Galenica, nine years after first investing in the company.

The firm, which invested in the company alongside Alliance Boots' executive chairman Stefano Pessina, has now fully exited its investment.

WSJ Logo